3/8/2012 — Richard L. Edelson, MD, chief of dermatology at Yale New Haven Hospital and Yale School of Medicine since 1986, will be honored later this month as one of three "National Physicians of the Year" at the seventh annual Castle Connolly Medical Ltd. National Awards in New York City.
Dr. Edelson and two other physicians were chosen by a committee of medical peers from among 150 nominees from around the country for excellence in clinical medical practice and tireless work in their respective field of medicine.
Dr. Edelson, the Aaron B. and Marguerite Lerner Professor of Dermatology at YSM, has also served as director of Yale Cancer Center (YCC), director of YCC's lymphoma research program and YSM deputy dean for clinical affairs. Dr. Edelson received his medical degree at the Yale School of Medicine and completed his internship in internal medicine at the University of Chicago and his residency in dermatology at the Massachusetts General Hospital.
In addition to his clinical work, Dr. Edelson is an internationally-recognized pioneer in the research and treatment of cutaneous T-cell lymphoma (CTCL), a commonly lethal cancer originating in the skin and spreading throughout the body. He identified and characterized this cancer, and his research group played a central role in deciphering the basic properties of CTCL cells in order to develop effective therapies.
Dr. Edelson developed extracorporeal photochemotherapy (ECP) for CTCL patients in clinical trials at Yale Cancer Center. ECP, the first FDA approved selective immunotherapy for any cancer, has been used more than 3 million times worldwide to treat CTCL, organ transplant rejection and graft-versus-host disease, the major complication following bone marrow transplantation.
Castle Connolly Medical is best known as the firm that publishes the "Top Doctors" series of books and as the producer of the Top Doctors database that appears on the website of U.S. News and World Report. The organization, whose mission is "to help consumers find the best healthcare in America," was founded in 1991.
8/20/2026
Yale New Haven Hospital receives American Heart Association’s Comprehensive Hypertension Center CertificationNew Haven, CT (August 20, 2026) – Yale New Haven Hospital has been awarded the American Heart Association’s Comprehensive Hypertension Center Certification, recognizing the hospital’s Hypertension Center’s commitment to following proven, research-based treatment guidelines to care for people with complex or difficult-to-treat hypertension, or high blood pressure
8/4/2026
Yale New Haven Hospital is the top hospital in Connecticut according to U.S. News & World ReportNEW HAVEN, CT (August 4, 2026) – Yale New Haven Hospital (YNHH) continues to rank among the top hospitals in the country according to U.S. News & World Report’s annual “America’s Best Hospitals” listing.
7/21/2026
Yale New Haven Hospital introduces innovative implantable technology to advance stroke rehabilitationNEW HAVEN, CT. — [July 21, 2026] — Every 40 seconds, someone in the United States has a stroke. Yale New Haven Hospital is bringing new hope to stroke survivors with the introduction of an innovative, FDA-approved device that enhances rehabilitation by combining traditional therapy with targeted nerve stimulation.